Electronic cigarettes and lung toxicity

  • Terrance Rodrigues Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX
  • Eric Deal
  • Kenneth Nugent
  • J. Drew Payne

Abstract

The use of electronic cigarettes (e-cigarettes) in the United States has steadily increased
since their introduction into the market in 2007. These devices deliver nicotine through the
vaporization of a liquid which contains a vehicle (propylene glycol or glycerin), artificial
flavoring, and nicotine. The combustion of these liquids creates a vapor containing particulates,
multiple chemicals, and nicotine. The long-term safety of these products is unknown. Studies
in healthy, non-smoking volunteers and smokers with no clinical pulmonary disease have
demonstrated that the inhalation of e-cigarette vapor has minimal short-term effects on
pulmonary function. The exposure of cell cultures to e-cigarette liquid or aerosols has been
shown to reduce cell viability, induce cytokine production, and cause oxidative stress. The
exposure of animals (mice and rats) to e-cigarette aerosols induces inflammatory responses
in the lungs and delays the clearance of bacterial and viral challenges. There are a small
number of case reports of patients developing acute pulmonary toxicity following the use of
e-cigarettes. Two patients have developed lipoid pneumonia following the use of e-cigarettes
for 3 and 7 months. Finally, several studies suggest that patients with chronic lung disease
who switch from tobacco cigarettes to e-cigarettes can have improvement in lung function
(asthmatics) and a reduction in the number of exacerbations (chronic obstructive pulmonary
disease). Clearly, the public and the medical profession need more information about the
long-term complications associated with the use of e-cigarettes and their benefit in smoking
cessation efforts.
Keywords: electronic

Downloads

Download data is not yet available.

References

Brown CJ, Cheng JM. Electronic cigarettes: product characterisation

and design considerations. Tob Control 2014;23

Suppl 2:ii4-10.

Orellana-Barrios MA, Payne D, Medrano-Juarez RM, Yang

S, Nugent K. Electronic Cigarettes for Smoking Cessation.

Am J Med Sci 2016;352:420-6.

McMillen RC, Gottlieb MA, Shaefer RM, Winickoff JP,

Klein JD. Trends in Electronic Cigarette Use Among U.S.

Adults: Use is Increasing in Both Smokers and Nonsmokers.

Nicotine Tob Res 2015;17:1195-202.

Flouris AD, Chorti MS, Poulianiti KP, et al. Acute impact

of active and passive electronic cigarette smoking on serum

cotinine and lung function. Inhal Toxicol 2013;25:91-101.

Ferrari M, Zanasi A, Nardi E, et al. Short-term effects of a

nicotine-free e-cigarette compared to a traditional cigarette

in smokers and non-smokers. BMC Pulm Med 2015;15:120.

Vardavas CI, Anagnostopoulos N, Kougias M, Evangelopoulou

V, Connolly GN, Behrakis PK. Short-term pulmonary

effects of using an electronic cigarette: impact on respiratory

flow resistance, impedance, and exhaled nitric oxide. Chest

;141:1400-6.

Polosa R, Morjaria J, Caponnetto P, et al. Effect of smoking

abstinence and reduction in asthmatic smokers switching to

electronic cigarettes: evidence for harm reversal. Int J Environ

Res Public Health 2014;11:4965-77.

Polosa R, Morjaria JB, Caponnetto P, et al. Evidence for

harm reduction in COPD smokers who switch to electronic

cigarettes. Respir Res 2016;17:166.

Allen JG, Flanigan SS, LeBlanc M, et al. Flavoring Chemicals

in E-Cigarettes: Diacetyl, 2,3-Pentanedione, and Acetoin

in a Sample of 51 Products, Including Fruit-, Candy-,

and Cocktail-Flavored E-Cigarettes. Environ Health Perspect

;124:733-9.

Atkins G. Acute inhalational lung injury related to the use

of electronic nicotine delivery system (ENDS). Chest 2015;

(4): doi: 10.1378/chest.2281610 (abstract).

Hureaux J, Drouet M, Urban T. A case report of subacute

bronchial toxicity induced by an electronic cigarette. Thorax

;69:596-7.

Moore K, Young H, Ryan M. Bilateral pneumonia and pleural

effusions subsequent to electronic cigarette use. Open

Journal of Emergency Medicine2015:18-22.

Thota D, Latham E. Case report of electronic cigarettes possibly

associated with eosinophilic pneumonitis in a previously

healthy active-duty sailor. J Emerg Med 2014;47:15-7.

McCauley L, Markin C, Hosmer D. An unexpected consequence

of electronic cigarette use. Chest 2012;141:1110-3.

Modi S, Sangani R, Alhajhusain A. Acute lipoid pneumonia

secondary to E-cigarettes use: an unlikely replacement for

cigarettes. Chest 2015; 148 (4): doi: 10.1378/chest.2274860

(absrtract).

Leigh NJ, Lawton RI, Hershberger PA, Goniewicz ML.

Flavourings significantly affect inhalation toxicity of aerosol

generated from electronic nicotine delivery systems

(ENDS). Tob Control 2016;25:ii81-ii7.

Scheffler S, Dieken H, Krischenowski O, Förster C, Branscheid

D, Aufderheide M. Evaluation of E-cigarette liquid

vapor and mainstream cigarette smoke after direct exposure

of primary human bronchial epithelial cells. Int J Environ

Res Public Health 2015;12:3915-25.

Schweitzer KS, Chen SX, Law S, et al. Endothelial disruptive

proinflammatory effects of nicotine and e-cigarette vapor exposures.

Am J Physiol Lung Cell Mol Physiol 2015;309:L175-87.

Lerner CA, Sundar IK, Yao H, et al. Vapors produced by electronic

cigarettes and e-juices with flavorings induce toxicity,

oxidative stress, and inflammatory response in lung epithelial

cells and in mouse lung. PLoS One 2015;10:e0116732.

Werley MS, Kirkpatrick DJ, Oldham MJ, et al. Toxicological

assessment of a prototype e-cigaret device and three flavor

formulations: a 90-day inhalation study in rats. Inhal Toxicol

;28:22-38.

Sussan TE, Gajghate S, Thimmulappa RK, et al. Exposure

to electronic cigarettes impairs pulmonary anti-bacterial

and anti-viral defenses in a mouse model. PLoS One

;10:e0116861.

Published
2017-05-05
How to Cite
Rodrigues, T., Deal, E., Nugent, K., & Payne, J. D. (2017). Electronic cigarettes and lung toxicity. The Southwest Respiratory and Critical Care Chronicles, 5(19), 16-21. https://doi.org/10.12746/swrccc.v5i19.394